Latest KFF Health News Stories
Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
Expertos elaboran nuevas recomendaciones para la detección del cáncer cervical
Un panel de expertos en prevención dice que las mujeres deberían alternar las pruebas de Papanicolau y VPH, en vez de hacerse las dos a la vez.
Prevention Experts Propose Easing Advice On Number Of Cervical Cancer Screenings
A draft recommendation from the U.S. Preventive Services Task Force says women between ages 30 and 65 should get a Pap test every three years or an HPV screening every five years, but they don’t need to do both.
Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía
Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.
Some Thyroid Cancer Patients Can Safely Delay Surgery
Study suggests that many small tumors are sleepy, not deadly.
Pioneering Cancer Gene Therapy Gets Green Light — And $475,000 Price Tag
The USA’s first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
Cáncer: cuando escribir ayuda a sanar
A través de la escritura expresiva, pacientes con cáncer logran canalizar sus miedos y ansiedades, y contar sus historias, en un inédito proceso creativo.
Writing Your Way Through Cancer
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Colon Cancer Rates Rising Among Younger White Adults — And Falling Among Blacks
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Safe Under The ACA, Patients With Preexisting Conditions Now Fear Bias
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Seniors Miss Out On Clinical Trials
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
Take Our Quiz To Test Your Wits On Aging
As we get older, it helps to tickle the noggin with trivia. Here’s a pop quiz to see what you have learned as a regular reader of Kaiser Health News.
“¿Cuánto tiempo me queda, doctor?” Por qué muchos pacientes con cáncer no obtienen respuestas
Muchas veces los pacientes con cáncer no reciben respuestas adecuadas a preguntas críticas, entre ellas, la más crucial y universal de todas.
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
